Skip to content

Clinical trials

Observational Myeloproliferative Disorders trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Observational Country / region: France Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20101
20151
20162
20171
20193
20203
20222
20236
20245
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting7
Unknown status6
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Brest7
University Hospital, Bordeaux5
Assistance Publique - Hôpitaux de Paris4
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS2
Centre Hospitalier Universitaire de Nice1
Centre Hospitalier Universitaire de Nīmes1
European Organisation for Research and Treatment of Cancer - EORTC1
French Innovative Leukemia Organisation1
Institut National de la Santé Et de la Recherche Médicale, France1
LEO Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders27
Thrombosis6
Leukemia4
Neoplasms3
Polycythemia Vera3
Thrombocythemia, Essential3
Breast Neoplasms2
Leukemia, Myeloid, Acute2
Lymphoma2
Lymphoproliferative Disorders2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.